News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LAV Biosciences Fund V, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/29/2022 |
SC 13G/A
| LAV Biosciences Fund V, L.P. reports a 6.2% stake in Terns Pharmaceuticals, Inc. |
| 11/28/2022 |
4
| LAV Biosciences Fund V, L.P. (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Sold 1,000,000 shares
@ $5.5, valued at
$5.5M
Sold 333,334 shares
@ $5.5, valued at
$1.8M
Sold 166,666 shares
@ $5.5, valued at
$916.7k
|
|
| 02/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2022 |
SC 13G
| LAV Biosciences Fund V, L.P. reports a 7.8% stake in Gracell Biotechnologies Inc. |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/16/2019 |
D
| Form D - Notice of Exempt Offering of Securities: |
|
|